Cary Street Partners Investment Advisory LLC Organon & Co. Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 07, 2024	BUY	$10.95 - $17.32 $13,972 - $22,100	1,276 New	1,276 $18,000
Q3 2023 Nov 13, 2023	BUY	$16.59 - $23.77 $7,017 - $10,054	423 Added 46.48%	1,333 $23,000
Q2 2023 Aug 10, 2023	SELL	$19.27 - $24.63 $4,971 - $6,354	-258 Reduced 22.09%	910 $18,000
Q1 2023 May 12, 2023	BUY	$21.42 - $32.08 $3,727 - $5,581	174 Added 17.51%	1,168 $27,000
Q4 2022 Feb 14, 2023	BUY	$23.31 - $28.61 $23,170 - $28,438	994 New	994 $27,000

Others Institutions Holding OGN

# of Institutions

791

Shares Held

193M

Call Options Held

1.71M

Put Options Held

865K

Black Rock Inc. New York, NY

32.6M
Shares

$498 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

30.2M
Shares

$461 Million
0.01% of portfolio
Massachusetts Financial Services CO Boston, MA

9.76M
Shares

$149 Million
0.06% of portfolio
State Street Corp Boston, MA

8.98M
Shares

$137 Million
0.01% of portfolio
Lsv Asset Management Chicago, IL

7.49M
Shares

$115 Million
0.31% of portfolio

View Full List

About Organon & Co.

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.89B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

More about OGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account